A review of pharmacokinetic drug-drug interactions with the anthelmintic medications albendazole and mebendazole. (2015)

Peer-Reviewed Study · Shane Ashley Pawluk; Craig Allan Roels; Kyle John Wilby et al. · April 2015

Shane Ashley Pawluk et al., 2015-04: Systematic review of 17 pharmacokinetic drug-interaction studies with albendazole and mebendazole, listing the agents that raise or lower exposure.

Cimetidine increased the elimination half-life of albendazole and maximum concentration (Cmax) of mebendazole; dexamethasone increased the area under the plasma concentration-time curve (AUC) of albendazole

Shane Ashley Pawluk et al., 2015-04: Systematic review of 17 pharmacokinetic drug-interaction studies with albendazole and mebendazole, listing the agents that raise or lower exposure. Study type: systematic review of pharmacokinetic interaction studies. N: 17 articles. Country: Qatar (Qatar University, Doha). Dose: not applicable (review of others' doses). Funder: not stated in the record. Declared conflicts: no COI statement in the record. Comparator: each interacting drug against the anthelmintic alone. Relevance to C7: exposure to mebendazole is modifiable by co-administered drugs, part of why blood levels vary. Also filed as MBD-24 (claims C5, C7). Study type: review.